Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Witte

Showing results (221-230 of 317) with videos related to

Pageof 32
Sort By:
Annals of the New York Academy of Sciences|September 28, 2007
Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosusYehuda Shoenfeld, Martine Szyper-Kravitz, Torsten Witte, et al.
Neurological Research and Practice|November 13, 2024
Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patientsKonstantin Fritz Jendretzky, Lisa-Marie Lezius, Thea Thiele, et al.
Zeitschrift Fur Rheumatologie|September 23, 2025
[Renewed increase in new Janus kinase inhibitor prescriptions : Analysis of the German RHADAR registry]Patrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, et al.
Frontiers in Immunology|September 6, 2024
Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective studyPatrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, et al.
Antiviral Research|July 30, 2023
Janus kinase-inhibition modulates hepatitis E virus infectionVolker Kinast, Ioana Andreica, Gerrit Ahrenstorf, et al.
Journal of Medical Internet Research|May 20, 2021
A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) RegistryStefan Kleinert, Peter Bartz-Bazzanella, Cay von der Decken, et al.
Annals of the Rheumatic Diseases|February 19, 2024
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohortIoannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
Autoimmunity Reviews|January 22, 2025
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.
Therapeutic Advances in Ophthalmology|November 4, 2024
Optical coherence tomography angiography to assess for retinal vascular changes in Neuro-SjögrenMelanie Haar, Franz Felix Konen, Marten A Gehlhaar, et al.
Annals of the Rheumatic Diseases|September 30, 2010
Analysis of the REL polymorphism rs13031237 in autoimmune diseasesJezabel Varadé, Rogelio Palomino-Morales, Norberto Ortego-Centeno, et al.
Pageof 32

Showing results (221-230 of 317) with videos related to

Sort By:
Pageof 32
Annals of the New York Academy of Sciences|September 28, 2007
Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosusYehuda Shoenfeld, Martine Szyper-Kravitz, Torsten Witte, et al.
Neurological Research and Practice|November 13, 2024
Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patientsKonstantin Fritz Jendretzky, Lisa-Marie Lezius, Thea Thiele, et al.
Zeitschrift Fur Rheumatologie|September 23, 2025
[Renewed increase in new Janus kinase inhibitor prescriptions : Analysis of the German RHADAR registry]Patrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, et al.
Frontiers in Immunology|September 6, 2024
Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective studyPatrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, et al.
Antiviral Research|July 30, 2023
Janus kinase-inhibition modulates hepatitis E virus infectionVolker Kinast, Ioana Andreica, Gerrit Ahrenstorf, et al.
Journal of Medical Internet Research|May 20, 2021
A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) RegistryStefan Kleinert, Peter Bartz-Bazzanella, Cay von der Decken, et al.
Annals of the Rheumatic Diseases|February 19, 2024
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohortIoannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
Autoimmunity Reviews|January 22, 2025
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.
Therapeutic Advances in Ophthalmology|November 4, 2024
Optical coherence tomography angiography to assess for retinal vascular changes in Neuro-SjögrenMelanie Haar, Franz Felix Konen, Marten A Gehlhaar, et al.
Annals of the Rheumatic Diseases|September 30, 2010
Analysis of the REL polymorphism rs13031237 in autoimmune diseasesJezabel Varadé, Rogelio Palomino-Morales, Norberto Ortego-Centeno, et al.
Pageof 32